Page last updated: 2024-09-03

alanyl-alanyl-phenylalanine chloromethyl ketone and Carcinoma, Anaplastic

alanyl-alanyl-phenylalanine chloromethyl ketone has been researched along with Carcinoma, Anaplastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carcoforo, P; Castelli, C; Fortini, C; Gavioli, R; Marescotti, D; Masucci, M; Preta, G1

Other Studies

1 other study(ies) available for alanyl-alanyl-phenylalanine chloromethyl ketone and Carcinoma, Anaplastic

ArticleYear
Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells.
    Scandinavian journal of immunology, 2008, Volume: 68, Issue:6

    Topics: Amino Acid Chloromethyl Ketones; Aminopeptidases; Antigen Presentation; Antigens, Neoplasm; Carcinoma; Cell Line, Tumor; Colonic Neoplasms; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Epitopes, T-Lymphocyte; HLA-A2 Antigen; Humans; Inhibitor of Apoptosis Proteins; Lymphocyte Activation; Microtubule-Associated Proteins; Neoplasm Proteins; Proteasome Endopeptidase Complex; Serine Endopeptidases; Serine Proteinase Inhibitors; Survivin; T-Lymphocytes, Cytotoxic

2008